ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,055Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 1107

$1.05M Total Retail Price of All Prescriptions

Rank: 84 out of 1107

443 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

34% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 7,353 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,074 231 S3 1 1
LISINOPRIL 707 252 2 2
METFORMIN HCL 688 321 3 8
HYDROCHLOROTHIAZIDE 563 213 4 11
LEVOTHYROXINE SODIUM 515 259 5 3
RANITIDINE HCL 478 178 6 21
GABAPENTIN 469 83 7 9
METOPROLOL SUCCINATE 406 189 8 16
ATORVASTATIN CALCIUM 389 177 9 13
SIMVASTATIN 361 182 10 5
FUROSEMIDE 360 172 11 7
TRAMADOL HCL 345 95 12 26
PRAVASTATIN SODIUM 317 50 13 12
OMEPRAZOLE 309 90 14 4
POTASSIUM CHLORIDE 289 149 15 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 287 77 16 24
METOPROLOL TARTRATE 269 91 17 10
NEXIUM 257 57 18 18
AMLODIPINE BESYLATE 255 176 19 6
NAPROXEN 246 26 20 80
ALENDRONATE SODIUM 240 86 21 41
LOVAZA 239 64 22 101
FENOFIBRATE 213 35 23 67
CRESTOR 209 70 24 23
TRAZODONE HCL 204 52 25 33
LOVASTATIN 203 53 26 55
ATENOLOL 185 78 27 19
CITALOPRAM HBR 183 32 28 17
ZOLPIDEM TARTRATE 181 67 29 22
PROAIR HFA 175 61 30 37
IBUPROFEN 168 83 31 63
TRICOR 165 101 32 95
CLOPIDOGREL 164 79 33 28
ZETIA 161 86 34 76
MELOXICAM 141 52 35 25
ALLOPURINOL 137 59 36 36
VOLTAREN 135 71 37 265
METHOCARBAMOL 134 0 R 38 142
LIPITOR 130 82 39 109
ONGLYZA 129 33 40 205
GLYBURIDE 128 50 R 41 68
TIZANIDINE HCL 122 24 42 73
PLAVIX 121 59 43 39
GLIPIZIDE ER 117 56 44 115
TRILIPIX 117 27 44 153
ADVAIR DISKUS 115 42 46 54
TAMSULOSIN HCL 114 64 47 30
LOSARTAN POTASSIUM 114 63 47 29
WARFARIN SODIUM 112 97 49 15
GLIMEPIRIDE 110 48 50 43
SERTRALINE HCL 109 16 51 20
CELEBREX 103 28 52 85
SINGULAIR 101 25 53 65
BUSPIRONE HCL 97 16 54 107
CYCLOBENZAPRINE HCL 92 0 R 55 56
GEMFIBROZIL 90 37 56 107
FINASTERIDE 88 43 57 130
NABUMETONE 87 29 58 181
LOSARTAN-HYDROCHLOROTHIAZIDE 87 37 58 66
PANTOPRAZOLE SODIUM 86 15 60 30
CLONIDINE HCL 85 70 61 53
LIDODERM 84 44 62 140
CYMBALTA 83 16 63 50
ACTONEL 82 39 64 306
FEXOFENADINE HCL 81 29 65 260
LANTUS 77 52 66 49
CARVEDILOL 77 33 66 27
ISOSORBIDE MONONITRATE ER 76 35 68 34
PAROXETINE HCL 75 17 69 45
ROPINIROLE HCL 72 27 70 69
TRAMADOL HCL-ACETAMINOPHEN 69 19 71 195
DIOVAN 67 47 72 51
BYSTOLIC 65 0 73 138
NASONEX 65 30 73 206
JANUVIA 61 44 75 60
LYRICA 60 0 76 83
ACETAMINOPHEN-CODEINE 59 0 S3 77 120
COMBIVENT 57 26 78 112
SPIRIVA 55 24 79 57
FLUTICASONE PROPIONATE 55 39 79 38
FOSINOPRIL SODIUM 54 31 81 278
QUINAPRIL HCL 53 18 82 145
DOXEPIN HCL 53 27 82 180
AMOXICILLIN 52 20 84 90
BACLOFEN 52 17 84 133
PHENYTOIN SODIUM EXTENDED 50 0 86 147
TRIAMCINOLONE ACETONIDE 50 19 86 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.